MIF and central nervous system cancer: Additionally, after Baf A1 treatment, there was no difference of MIF expression in FOXG1-silenced group with or without Baf A1 treatment; however, LC3II expression was remarkably elevated in FOXG1-silenced glioma cells compared to the other groups (Fig. 6B).